Drawing for CELMATIX

USPTO serial 90315711

CELMATIX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SCLEIDOROVICH, JOANNA YAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELMATIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alyssa M. Worsham

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
035Reporting scientific and clinical data in the field of women's health and ovarian health for business purposes for use by the biomedical industries in the nature of business research; providing an online database featuring scientific data, clinical data and research information in the fields of women's health and ovarian health in the nature of business researchACTIVE—
042Providing an online database featuring scientific data, clinical data and research information in the fields of women's health and ovarian health for scientific research purposes; Pharmaceutical drug development services; data capture, analysis and reporting of clinical data in the field of women's health and ovarian health for the purpose of measuring and improving the quality of women's health care in the nature of scientific research; providing a web site featuring technology enabling women's health care providers to access resources related to women's health and ovarian health; Scientific services, namely, providing scientific analysis and scientific research informational reports based upon results of laboratory testing in the fields of women's health and ovarian health; Scientific services, namely, providing scientific research information in the fields of women's health and medicine and ovarian health and medicine; Scientific services, namely, scientific research in the field of women's health and medicine and ovarian health and medicine; providing temporary use of non-downloadable software featuring a comprehensive database on outcomes related to women's health, ovarian health and associated outcomes; Scientific services, namely, providing scientific research and analysis services in the field of women's cancer therapy, care, and treatment of cancer patients; Scientific services, namely, conducting scientific research and analysis relating to outcomes research in women's health and cancer; Scientific services, namely, scientific research and analysis in the fields of cancer research, and health policy concerning cancer and women's reproductive issues; providing scientific research information in the fields of medical research, pharmaceutical development and clinical trials; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in medical research and pharmaceutical development; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in the women's health field for the purpose of research, development, and commercialization; providing a website featuring educational information in the fields of medical research, pharmaceutical development, clinical trials and artificial intelligenceACTIVE—
044Providing health information via a website in the fields of women's health and ovarian health; consulting services in the field of diagnostic medical testing in the field of women's health and ovarian health; predictive modeling of data relating to women's health and ovarian health in the nature of health assessment servicesACTIVE—
045Licensing of intellectual property rightsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 7, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 7, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 26, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 26, 2024EX5GSOU EXTENSION 5 GRANTED—
Jun 26, 2024EXT5SOU EXTENSION 5 FILED—
Jun 26, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 23, 2024EX4GSOU EXTENSION 4 GRANTED—
Jan 23, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 4, 2024EXT4SOU EXTENSION 4 FILED—
Jan 4, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 30, 2023EX3GSOU EXTENSION 3 GRANTED—
Jun 30, 2023EXT3SOU EXTENSION 3 FILED—
Jun 30, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 6, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 4, 2023EX2GSOU EXTENSION 2 GRANTED—
Jan 4, 2023EXT2SOU EXTENSION 2 FILED—
Jan 4, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2022EX1GSOU EXTENSION 1 GRANTED—
Jun 24, 2022EXT1SOU EXTENSION 1 FILED—
Jun 24, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 4, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 6, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 6, 2021DOCKASSIGNED TO EXAMINER—
Sep 22, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 26, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 26, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2021DOCKASSIGNED TO EXAMINER—
Jan 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance